Fisher to buy Athena, stake in Nanogen

Fisher agreed to buy privately held medical test maker Athena Diagnostics Inc. for $283 million cash from investment firm Behrman Capital, as well as a minority interest in biotech company Nanogen Inc. for $15.1 million.

Fisher to buy Athena, stake in Nanogen


BioBOOM Op/Ed: The move is on in MDx acquizition and investments (See Asuragen from Ambion too). Be prepared for assimilation. Third Wave can only hope to be next for someone so they can be put out of their misery. Of course there are some bad risks and losers out there too. Call us if you'd like to be warned.

No comments:

Blog Archive